我要投票 半边天NEWOMEN在乌鸡白凤丸行业中的票数:539
· 外 推 电 报 ·
2025-11-22 16:53:41 星期六

【半边天NEWOMEN是哪个国家的品牌?】

半边天NEWOMEN是什么牌子?「半边天NEWOMEN」是 江西半边天药业有限公司 旗下著名品牌。该品牌发源于香港,由创始人翁汉辉在1998-04-14期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力半边天NEWOMEN品牌出海!将品牌入驻外推网,定制半边天NEWOMEN品牌推广信息,可以显著提高半边天NEWOMEN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

始于1998年,香港半边天药业国际集团旗下,专注妇科中成药、保健品的研发、生产、销售的制药公司


半边天药业国际集团(香港)有限公司成立于一九九八年四月,目前拥有江西半边天药业有限公司、深圳市半边天保健品有限公司、深圳市金药坊医药有限公司等多家下属企业,并在江西省泰和经济开发区建有占地十六万余平方米的生产基地——半边天药业国际集团工业城,固定资产规模达人民币2亿多元,其国内总部设在深圳。

半边天药业国际集团本着“专心造好药,健康半边天”的经营宗旨,专注妇科中成药、保健品的研发、生产、销售,已形成具有调经类、乳腺类、补血类、消炎类、排毒类等多种功能的妇科产品线,主要品种有国家中药保护品种和新药复方乌鸡口服液、乳宁丸、阿胶益寿口服液、乌鸡白凤丸、芦荟胶囊、妇舒洁洗液、妇炎康片等。

半边天药业国际集团下属的成员企业江西半边天药业拥有:口服液、糖浆、蜜丸、水丸、洗液等多条具有国内专业水平的生产线;生产能力10亿元以上;2004年和2009年两次通过国家药监局的GMP认证。目前正在建设中的二期工程包括了片剂、胶囊剂、颗粒剂等多种剂型。二期工程预计2012年完工建成。

半边天药业国际集团坚持以市场为导向,下属成员企业深圳金药坊医药有限公司是集团公司的营销中心,已于二OO四年六月顺利通过GSP认证,目前已建成以深圳为中心,辐射华南、华东、中南、西南的销售网络,在广东、广西、云南、贵州、湖南、湖北、重庆、四川、江苏、江西、安徽、浙江、山东等二十多个省、直辖市、自治区设立了二百多个营销分支机构,建立了一千多人的专业销售队伍。

半边天药业国际集团注重科技创新,与国内外多家医药研究机构建立了密切合作关系,实现了产品研发、信息交流、市场开拓、人才培养友好互动,生产、储备、研制、构想齐头并进的良好发展格局。

未来,半边天药业国际集团将继续“专业妇科品牌”的道路,通过并购、合作等多种途径,丰富产品群,扩大销售规模,进一步提升品牌影响力,积极寻求上市,实现中国医药市场妇科品牌的战略目标。


英文翻译:Started in 1998, half sky Pharmaceutical International Group (Hong Kong) Co., Ltd., a pharmaceutical company under half sky Pharmaceutical International Group in Hong Kong, which focuses on the research and development, production and sales of Chinese medicine for gynecology and health care products, was founded in April 1998. At present, it has Jiangxi half sky Pharmaceutical Co., Ltd., Shenzhen half sky health care products Co., Ltd., Shenzhen Golden Pharmaceutical Co., Ltd., etc There are more than 160000 square meters of production base - banbiantian Pharmaceutical International Group Industrial City in Taihe Economic Development Zone of Jiangxi Province, with fixed assets of more than 200 million yuan. Its domestic headquarters is located in Shenzhen. Based on the business tenet of "concentrate on making medicine, healthy half sky", banbiantian Pharmaceutical International Group focuses on the R & D, production and sales of Chinese traditional medicine and health care products in gynecology. It has formed a gynecology product line with multiple functions such as menstrual regulation, breast, blood tonic, anti-inflammatory, detoxification, etc. the main varieties are national traditional Chinese medicine protection varieties and new compound Wuji oral liquid, runing pill, a Jiaoyishou oral liquid, Wuji Baifeng pill, aloe capsule, fushujie lotion, Fuyankang tablet, etc. Jiangxi banbiantian Pharmaceutical Co., Ltd., a member enterprise of banbiantian Pharmaceutical International Group, has many production lines with domestic professional level, such as oral liquid, syrup, honey pill, water pill, lotion, etc.; the production capacity is more than 1 billion yuan; in 2004 and 2009, it passed the GMP certification of the State Food and Drug Administration twice. At present, the second phase project under construction includes tablet, capsule, granule and other dosage forms. The second phase of the project is expected to be completed in 2012. Banbiantian Pharmaceutical International Group adheres to the market orientation, and its subordinate member company Shenzhen jinyaofang Pharmaceutical Co., Ltd. is the marketing center of the group company. It has successfully passed the GSP certification in June 2004. At present, it has established a sales network with Shenzhen as the center, radiating South China, East China, Central South China and southwest China. It is located in Guangdong, Guangxi, Yunnan, Guizhou, Hunan, Hubei, Chongqing and Siyuan Sichuan, Jiangsu, Jiangxi, Anhui, Zhejiang, Shandong and more than 20 provinces, municipalities and autonomous regions have set up more than 200 marketing branches and established a professional sales team of more than 1000 people. Banbiantian Pharmaceutical International Group attaches great importance to scientific and technological innovation, and has established close cooperation with a number of pharmaceutical research institutions at home and abroad. It has achieved a good development pattern of product research and development, information exchange, market development, friendly interaction of talent training, and simultaneous development of production, reserves, research and ideas. In the future, banbiantian Pharmaceutical International Group will continue to be a "professional gynecological brand", enrich the product group, expand the sales scale, further enhance the brand influence, actively seek listing, and achieve the strategic goal of gynecological brand in China's pharmaceutical market through M & A, cooperation and other ways.

本文链接: https://www.waitui.com/brand/fae4e258c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

报告:“成分党”成为美妆主流消费群体

毕马威近日发布的《"颜"值经济新篇章:2025年中国美妆市场行业报告》(以下简称《报告》)显示,据调查,58.8%的消费者将产品成分作为购买决策的首要考量因素,“成分党”成为主流消费群体。与此同时,300-500元中端价格带产品市场份额显著提升,而超低价与高端市场则双双承压,反映出消费者在追求"悦己"体验的同时,更加注重产品的实际功效与性价比。(新浪财经)

54分钟前

美联储传声筒:鲍威尔不是降息的最大障碍 美联储内部共识机制濒临瓦解

“美联储传声筒”Nick Timiraos撰文称,特朗普本周表示,他预计在明年5月任命新的美联储主席后,利率将大幅下降。然而,美联储内部反对12月降息声浪越来越大,这意味着他的愿望可能难以实现。无论鲍威尔在12月选择按兵不动还是降息,他都面临近八年任期内最严重的内部阻力。这种分歧可能延续至明年,这意味着,即便更换主席,也并不等于就能确保会有更多降息。一些人担忧,若特朗普无法如愿以偿,可能会采取更激进手段削弱央行独立性,以换取降息。(金十数据APP)

54分钟前

第八届进博会,上海合作交流采购团达成意向采购额7.12亿元

11月21日下午,第八届中国国际进口博览会上海市合作交流采购团总结展示交流活动在闵行区虹桥品汇成功举办。据介绍,本届进博会上海市合作交流采购团采购成交再创新高,共达成意向采购额7.12亿元人民币,比上届提升4.71%,累计意向采购额突破30亿元。采购团规模也进一步扩大,分团总数增至33家,共组织30批次、近760人次走进进博会参观交流,参与企业数量创历年新高。(界面新闻)

54分钟前

《哪吒2》不参加奥斯卡竞逐

当地时间11月21日,奥斯卡奖的主办方美国电影艺术与科学学院公布了符合资格参与最佳纪录长片、最佳国际影片以及最佳动画长片三个奖项竞逐的影片大名单。在最佳动画长片领域,今年有35部影片有资格“冲奥”,意外的是,《哪吒之魔童闹海》并不在其中。另一方面,《罗小黑战记2》榜上有名。(澎湃新闻)

54分钟前

IDEA研究院孵化企业视启未来获近亿元融资

36氪获悉,孵化自IDEA研究院的视觉大模型企业,视启未来(深圳)科技有限公司宣布完成近亿元天使轮融资。本轮由A股上市公司安凯微领投,昊辰资本、德虎资本、元禾璞华、银杏谷资本、力合中科、数字未来、九安智能等机构跟投。

54分钟前

本页详细列出关于半边天NEWOMEN的品牌信息,含品牌所属公司介绍,半边天NEWOMEN所处行业的品牌地位及优势。
咨询